With the industry moving towards personalized prescribing, pharmacists have become the key to successful pharmacogenomics (PGx) implementation. In this episode of the Precision Insights Podcast, Adrijana Kekic, PGx pharmacist and the program director of education, outpatient pharmacy at the Mayo Clinic, delves into the ways...
All TreatGx users now have access to the updated Chronic Pain - Neuropathic Pain treatment algorithm. Finding the optimal therapy to meet goals for chronic pain management can be challenging. This major update not only brings together information from multiple sources but enables it to...
Introducing pharmacogenetics to a group of people, a population, can be tricky, but maintaining focus on patient experience, outcomes, and wellbeing can help. In this episode of Precision Insights, Curt Dame, VP of Health Solutions at Aon, explains his experience with implementing pharmacogenetics (PGx) into...
We are pleased to announce the addition of two new conditions to our TreatGx medication decision support system. Alzheimer’s Disease and Insomnia can now be accessed by all TreatGx users. The Alzheimer’s algorithm provides treatment options for adults with mild, moderate, or severe Alzheimer’s disease, and includes guidance on medication titration and switching. Treatment options and dosing are based on the most up-to-date...
The GenXys algorithm for Smoking Cessation has been updated and the new version is available to all TreatGx users. To continue to provide effective medication options and strategies for smoking cessation, we reviewed and incorporated information from recent guidelines and papers. These include the 2018 NICE guideline [1] and the 2018 American College of Cardiology expert consensus decision pathway [2]. We also included evidence from a recent Cochrane review on the use of different doses, durations...
